CERo Therapeutics Warrants
CEROW
CEROW was delisted on the 30th of October, 2025.
35 hedge funds and large institutions have $4.21M invested in CERo Therapeutics Warrants in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
17% more funds holding
Funds holding: 30 → 35 (+5)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
40% less capital invested
Capital invested by funds: $6.98M → $4.21M (-$2.78M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$111K |
| 2 |
LA
Linden Advisors
New York
|
+$92.8K |
| 3 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
+$92.8K |
| 4 |
CCM
Context Capital Management
Lajolla,
California
|
+$74.3K |
| 5 |
Parallax Volatility Advisers
San Francisco,
California
|
+$42.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CSS LLC
Chicago,
Illinois
|
-$12K |
| 2 |
D.E. Shaw & Co
New York
|
-$11K |
| 3 |
CF
Cantor Fitzgerald
New York
|
-$4.25K |
| 4 |
RA
Ramius Advisors
New York
|
-$4K |
| 5 |
CS
Clear Street
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TCM
26
Tenor Capital Management
New York
| $11K | – | – | – |
|
|
HIM
27
HGC Investment Management
Toronto,
Ontario, Canada
| $11K | +$18.6K | +50,000 | New |
|
|
BI
28
Bulldog Investors
Saddle Brook,
New Jersey
| $11K | +$20.3K | +54,745 | New |
|
|
HF
29
HRT Financial
New York
| $6K | – | – | – |
|
30
Hudson Bay Capital Management
Stamford,
Connecticut
| $6K | – | – | – |
|
|
RCM
31
Rivernorth Capital Management
West Palm Beach,
Florida
| $5K | – | – | – |
|
|
WA
32
Whitebox Advisors
Minneapolis,
Minnesota
| $5K | – | – | – |
|
|
VF
33
Virtu Financial
New York
| $3K | -$211 | -567 | -3% |
|
|
DCM
34
Dupont Capital Management
Wilmington,
Delaware
| $3K | – | – | – |
|
|
WP
35
Woodline Partners
San Francisco,
California
| $2K | – | – | – |
|
|
AA
36
Ancora Advisors
Cleveland,
Ohio
| $1K | +$929 | +2,500 | New |
|
|
37
D.E. Shaw & Co
New York
| – | -$11K | -25,000 | Closed |
|
|
RA
38
Ramius Advisors
New York
| – | -$4K | -10,000 | Closed |
|
|
CS
39
Clear Street
New York
| – | -$2K | -5,797 | Closed |
|
CEROW Hedge Fund Activity: Q1 2022 in Review
35 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q1 2022, worth a combined $4.21M — down 40% from $6.98M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CEROW positions and 3 closed out — a net gain of 5 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Periscope Capital, opening a new position worth an estimated $111K. The largest seller was CSS LLC, cutting an estimated $12K.
- 35 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q1 2022, up from 30 in Q4 2021.
- Funds reported $4.21M of CERo Therapeutics Warrants stock for Q1 2022, down 40% quarter-over-quarter.
- 8 funds opened new CERo Therapeutics Warrants positions in Q1 2022 and 3 closed out, a net change of +5 holders.
- The largest CERo Therapeutics Warrants buyer in Q1 2022 was Periscope Capital, an estimated $111K added.
- The largest CERo Therapeutics Warrants seller in Q1 2022 was CSS LLC, an estimated $12K sold.
Based on aggregated 13F filings for Q1 2022.